RecruitingNot ApplicableNCT05285527
MiSight 1 Day Safety Post-Approval Study
Sponsor
CooperVision, Inc.
Enrollment
2,400 participants
Start Date
Aug 15, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this post-approval study is to confirm the safety of daily disposable soft contact lens wear among the intended patient population for the MiSight 1 Day lens in the US.
Eligibility
Min Age: 8 YearsMax Age: 12 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called MiSight 1 Day for people with myopia. The study is currently recruiting participants at 50 locations. People eligible for this study include aged 8 Years to 12 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEMiSight 1 Day
Subjects will wear MiSight 1 day lenses for three years.
Locations(50)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05285527
Related Trials
Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among Youth
NCT076530741 location
Longitudinal Measurements of Visual Diet in Children
NCT076429991 location
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
NCT0709589412 locations
Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children
NCT069959111 location
Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial
NCT0756704014 locations